Launch of first ever rapid, objectively-scored GP assessment to differentiate between patients with memory loss due to the earliest signs of Alzheimer’s disease and normal memory loss caused by ageing.
Innovation on the strength of a simple test identified in a new study would enable intervention before damage is done.
Recent funding of over $5 million to Dr Sabine Bahn by the Stanley Medical Research Institute (SMRI) raises diagnostic and therapeutic hopes for a group of psychiatric diseases that affects 2% of the population.
© 2024 University of Cambridge